Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhou Tongde Pharmaceutical is a Beijing-based biopharmaceutical company specializing in the research, development, and commercialization of innovative drugs and modernized traditional medicines. The company focuses on high-impact therapeutic areas including oncology, cardiovascular diseases, and metabolic disorders. Shenzhou Tongde is known for its work in small molecule synthesis and the development of standardized natural extracts, such as Ginkgo biloba-based therapies. By integrating modern pharmaceutical technology with established medicinal insights, the firm aims to address unmet medical needs within the Chinese healthcare market. Its operations span the entire drug development value chain, from early-stage discovery and clinical trials to manufacturing and distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhou Tongde Pharmaceutical.